Announcements Trials

Browse Landscape

Phase

Phase 2 21 Phase 3 15 Phase 1 10 Phase 1/2 6 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 21 fludarabine phosphate 13 Cyclosporine 11 Antilymphocyte Serum 11 Peripheral Blood Stem Cell Transplantation 10 Methotrexate 10 Busulfan 10 Cytarabine 9 Filgrastim 8 Radiotherapy 7 Dexamethasone 7 Whole-Body Irradiation 6 Mycophenolic Acid 6 Methylprednisolone 6 Melphalan 6 Exercise 6 fludarabine 5 Vincristine 5 Daunorubicin 5 Cord Blood Stem Cell Transplantation 5 pegaspargase 4 Rituximab 4 Palliative Care 4 Mercaptopurine 4 Etoposide 4 Early Intervention, Educational 4 Blood Specimen Collection 4 Asparaginase 4 Alemtuzumab 4 Thioguanine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Leukemia × Mitoxantrone × Clear all

NCT00550992 2019-07-30

Interfant06

Dutch Childhood Oncology Group

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡